173 related articles for article (PubMed ID: 33822325)
1. LINC00200 contributes to the chemoresistance to oxaliplatin of gastric cancer cells via regulating E2F1/RAD51 axis.
Lin M; Xu M; Xu Z; Weng Z; Lin B; Lan Y; Liu Q; Lin X; Pan J
Hum Cell; 2021 Jul; 34(4):1163-1173. PubMed ID: 33822325
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of Long Non-coding RNA LINC00200 Inhibits Gastric Cancer Progression by Regulating miR-143-3p/SERPINE1 Axis.
He W; Zhang D; Li D; Zhu D; Geng Y; Wang Q; He J; Wu J
Dig Dis Sci; 2021 Oct; 66(10):3404-3414. PubMed ID: 33141390
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of miR-34c after silencing E2F transcription factor 1 inhibits paclitaxel combined with cisplatin resistance in gastric cancer cells.
Zheng H; Wang JJ; Yang XR; Yu YL
World J Gastroenterol; 2020 Feb; 26(5):499-513. PubMed ID: 32089626
[TBL] [Abstract][Full Text] [Related]
4. E2F1-regulated long non-coding RNA RAD51-AS1 promotes cell cycle progression, inhibits apoptosis and predicts poor prognosis in epithelial ovarian cancer.
Zhang X; Liu G; Qiu J; Zhang N; Ding J; Hua K
Sci Rep; 2017 Jun; 7(1):4469. PubMed ID: 28667302
[TBL] [Abstract][Full Text] [Related]
5. E2F1 induces TINCR transcriptional activity and accelerates gastric cancer progression via activation of TINCR/STAU1/CDKN2B signaling axis.
Xu TP; Wang YF; Xiong WL; Ma P; Wang WY; Chen WM; Huang MD; Xia R; Wang R; Zhang EB; Liu YW; De W; Shu YQ
Cell Death Dis; 2017 Jun; 8(6):e2837. PubMed ID: 28569791
[TBL] [Abstract][Full Text] [Related]
6. miR-135a promotes gastric cancer progression and resistance to oxaliplatin.
Yan LH; Chen ZN; Li-Li ; Chen J; Wei WE; Mo XW; Qin YZ; Lin Y; Chen JS
Oncotarget; 2016 Oct; 7(43):70699-70714. PubMed ID: 27683111
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA NNT-AS1 sponges miR-424/E2F1 to promote the tumorigenesis and cell cycle progression of gastric cancer.
Chen B; Zhao Q; Guan L; Lv H; Bie L; Huang J; Chen XB
J Cell Mol Med; 2018 Oct; 22(10):4751-4759. PubMed ID: 30006956
[TBL] [Abstract][Full Text] [Related]
8. The long non-coding RNA DDX11-AS1 facilitates cell progression and oxaliplatin resistance via regulating miR-326/IRS1 axis in gastric cancer.
Song W; Qian Y; Zhang MH; Wang H; Wen X; Yang XZ; Dai WJ
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3049-3061. PubMed ID: 32271422
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA BLACAT1 modulates ABCB1 to promote oxaliplatin resistance of gastric cancer via sponging miR-361.
Wu X; Zheng Y; Han B; Dong X
Biomed Pharmacother; 2018 Mar; 99():832-838. PubMed ID: 29710482
[TBL] [Abstract][Full Text] [Related]
10. E2F1-activated SPIN1 promotes tumor growth via a MDM2-p21-E2F1 feedback loop in gastric cancer.
Lv BB; Ma RR; Chen X; Zhang GH; Song L; Wang SX; Wang YW; Liu HT; Gao P
Mol Oncol; 2020 Oct; 14(10):2629-2645. PubMed ID: 32767629
[TBL] [Abstract][Full Text] [Related]
11. Gastric cancer derived mesenchymal stem cells promoted DNA repair and cisplatin resistance through up-regulating PD-L1/Rad51 in gastric cancer.
Wang Q; Huang C; Wang D; Tao Z; Zhang H; Zhao Y; Wang M; Zhou C; Xu J; Shen B; Zhu W
Cell Signal; 2023 Jun; 106():110639. PubMed ID: 36842523
[TBL] [Abstract][Full Text] [Related]
12. E2F1-induced upregulation of long noncoding RNA LINC00668 predicts a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically silencing of CKIs.
Zhang E; Yin D; Han L; He X; Si X; Chen W; Xia R; Xu T; Gu D; De W; Guo R; Xu Z; Chen J
Oncotarget; 2016 Apr; 7(17):23212-26. PubMed ID: 27036039
[TBL] [Abstract][Full Text] [Related]
13. Circular RNA circ_0032821 contributes to oxaliplatin (OXA) resistance of gastric cancer cells by regulating SOX9 via miR-515-5p.
Zhong Y; Wang D; Ding Y; Tian G; Jiang B
Biotechnol Lett; 2021 Feb; 43(2):339-351. PubMed ID: 33123829
[TBL] [Abstract][Full Text] [Related]
14. PCAT-1 contributes to cisplatin resistance in gastric cancer through miR-128/ZEB1 axis.
Guo Y; Yue P; Wang Y; Chen G; Li Y
Biomed Pharmacother; 2019 Oct; 118():109255. PubMed ID: 31352238
[TBL] [Abstract][Full Text] [Related]
15. NFYB-induced high expression of E2F1 contributes to oxaliplatin resistance in colorectal cancer via the enhancement of CHK1 signaling.
Fang Z; Gong C; Yu S; Zhou W; Hassan W; Li H; Wang X; Hu Y; Gu K; Chen X; Hong B; Bao Y; Chen X; Zhang X; Liu H
Cancer Lett; 2018 Feb; 415():58-72. PubMed ID: 29203250
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA ZNF674-AS1 antagonizes oxaliplatin resistance of gastric cancer via regulating EZH2-mediated methylation of CHST7.
Ye K; Wang Y
Aging (Albany NY); 2022 Jul; 14(13):5523-5536. PubMed ID: 35802620
[TBL] [Abstract][Full Text] [Related]
17. The long noncoding RNA LINC00200 promotes the malignant progression of MYCN-amplified neuroblastoma via binding to insulin like growth factor 2 mRNA binding protein 3 (IGF2BP3) to enhance the stability of Zic family member 2 (ZIC2) mRNA.
Chen J; Sun M; Huang L; Fang Y
Pathol Res Pract; 2022 Sep; 237():154059. PubMed ID: 35969939
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori infection related long noncoding RNA (lncRNA) AF147447 inhibits gastric cancer proliferation and invasion by targeting MUC2 and up-regulating miR-34c.
Zhou X; Chen H; Zhu L; Hao B; Zhang W; Hua J; Gu H; Jin W; Zhang G
Oncotarget; 2016 Dec; 7(50):82770-82782. PubMed ID: 27835575
[TBL] [Abstract][Full Text] [Related]
19. A miR-567-PIK3AP1-PI3K/AKT-c-Myc feedback loop regulates tumour growth and chemoresistance in gastric cancer.
Zhang F; Li K; Yao X; Wang H; Li W; Wu J; Li M; Zhou R; Xu L; Zhao L
EBioMedicine; 2019 Jun; 44():311-321. PubMed ID: 31078520
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
Cheng C; Qin Y; Zhi Q; Wang J; Qin C
Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
